SCR 18: REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.
- Session Year: 2025-2026
- House: Senate
- Latest Version Date: 2026-02-05
Current Status:
In Progress
(2026-02-13: Referred to HHS, WAM.)
Introduced
First Committee Review
First Chamber
Second Committee Review
Second Chamber
Final Decking
Enacted
Version:
REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.